Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value
FORT WORTH, Texas--(BUSINESS WIRE)--Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management.
OMCL's expanding SaaS pipeline, global push and solid solvency highlight growth potential despite rising competition.
Capital Fund Management S.A. grew its stake in shares of Omnicell, Inc. (NASDAQ: OMCL) by 97.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show.
The consensus price target hints at a 30.9% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference.
Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option fo
Campbell and CO Investment Adviser LLC lowered its holdings in shares of Omnicell, Inc. (NASDAQ: OMCL) by 85.0% during the undefined quarter, according to its most recent Form 13F filing with the Secu
Acadian Asset Management LLC grew its holdings in Omnicell, Inc. (NASDAQ: OMCL) by 33.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies.
The consensus price target hints at a 34.5% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for thos
Five robotics-driven stocks - PATH, EMR, TRMB, OMCL and LECO - are set to gain traction heading into late 2025.
Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two stocks offers value investors a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE